ArticleJACC. Case reports2026
Percutaneous Vegetectomy for Severe Right-Sided Infective Endocarditis Complicated by Cardiac Arrest and Multiorgan Failure.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRight-sided infective endocarditis (RSIE) is a life-threatening condition predominantly affecting the tricuspid valve. For patients with prohibitive surgical risk, percutaneous vegetectomy (PV) is emerging as a viable alternative. CASE SUMMARY: A 38-year-old man with active intravenous drug use presented with cardiac arrest, profound shock, and multiorgan dysfunction. Echocardiography revealed a large tricuspid valve vegetation (2.0 × 3.1 cm) with severe regurgitation. Because of high surgical risk, he underwent salvage PV using the AngioVac system. The procedure achieved 90% debulking, leading to marked hemodynamic improvement and successful weaning of vasoactive agents. He was subsequently discharged to complete antimicrobial therapy pending reassessment for definitive surgery. DISCUSSION: Although PV is increasingly used for RSIE, data regarding its use in extreme hemodynamic instability remain limited. Our case highlights its utility as a temporizing, life-saving intervention to reduce microbial burden and provide critical source control when definitive surgical debridement is not feasible. TAKE-HOME MESSAGES: PV is a viable rescue strategy for RSIE in high-risk patients. It provides critical source control to stabilize hemodynamics and bridge patients to recovery or definitive surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.